dr. zamarin on lenvatinib plus pembrolizumab in endometrial cancer
Published 7 years ago • 287 plays • Length 0:52Download video MP4
Download video MP3
Similar videos
-
1:22
dr. zamarin on the role of pembrolizumab in endometrial cancer
-
1:39
dr. makker on synergy between lenvatinib and pembrolizumab in endometrial cancer
-
1:32
dr. makker on safety signals with lenvatinib and pembrolizumab in endometrial cancer
-
0:53
dr. backes on next steps for lenvatinib and weekly paclitaxel in endometrial cancer
-
4:02
#esmo19: lenvatinib (len) and pembrolizumab (pembro) in advanced endometrial cancer
-
3:28
keynote-775 subgroup analysis in advanced endometrial cancer
-
36:22
modern, molecularly informed therapy for patients with advanced endometrial cancer
-
1:44
dr. zamarin on priming strategies in ovarian cancer
-
0:52
dr. zamarin on the future treatment landscape of gynecologic malignancies
-
0:52
investigating toxicities with lenvatinib plus paclitaxel in ovarian and endometrial cancers
-
12:35
final study results of keytruda® plus lenvima® for advanced endometrial cancer
-
11:39
transforming second-line immunotherapy for endometrial cancer
-
8:23
high reward, high toxicity: combination pembrolizumab and lenvatinib in advanced endometrial cancer
-
0:55
dr. backes on safety profile of lenvatinib and weekly paclitaxel in endometrial cancer
-
3:24
endometrial cancer health outcomes: pembrolizumab for patients with msi-high endometrial cancer
-
0:49
research priorities for metastatic endometrial cancer
-
0:46
modest response rates in endometrial cancers
-
0:48
dr. cabanillas on lenvatinib as first-line therapy for patients with dtc
-
1:00
#advanced #cancer #nice #plus #lenvatinib #endometrial #treated #previously #pembrolizumab #recommen